Gloucester Pharmaceuticals, Inc.
Overview
Gloucester Pharmaceuticals, Inc. was a biopharmaceutical company focused on the development of novel therapeutics for the treatment of cancer. It was acquired by Celgene Corporation, making it a subsidiary dedicated to enhancing Celgene's oncology portfolio.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Gloucester Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.